Cybin IncCBOE Canada:CYBNView on NYSE American
- LAST PRICE0.4800
- TODAY'S CHANGE (%)-0.0050 (-1.0309%)
- Bid / Lots0.4600/ 22
- Ask / Lots0.4800/ 2
- Open / Previous Close0.4900 / 0.4850
- Day Range
- 52 Week Range
- Volume213,488
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CYBN |
|---|---|---|
| 09:32 ET | 500 | 0.5 |
| 09:36 ET | 1500 | 0.49 |
| 09:41 ET | 2000 | 0.49 |
| 09:45 ET | 54500 | 0.47 |
| 09:48 ET | 11500 | 0.475 |
| 09:50 ET | 1500 | 0.47 |
| 10:10 ET | 6000 | 0.48 |
| 10:15 ET | 8500 | 0.47 |
| 10:19 ET | 2000 | 0.48 |
| 10:46 ET | 2000 | 0.48 |
| 10:48 ET | 5000 | 0.48 |
| 10:50 ET | 1000 | 0.475 |
| 10:57 ET | 500 | 0.48 |
| 11:13 ET | 2500 | 0.48 |
| 12:02 ET | 2500 | 0.475 |
| 12:05 ET | 2000 | 0.47 |
| 12:07 ET | 1500 | 0.47 |
| 12:09 ET | 2500 | 0.47 |
| 12:12 ET | 20000 | 0.47 |
| 12:20 ET | 3000 | 0.465 |
| 12:25 ET | 5500 | 0.465 |
| 12:27 ET | 8500 | 0.465 |
| 12:38 ET | 4500 | 0.465 |
| 12:54 ET | 5500 | 0.47 |
| 12:56 ET | 3500 | 0.465 |
| 12:59 ET | 1500 | 0.465 |
| 01:14 ET | 1500 | 0.47 |
| 01:32 ET | 1000 | 0.4675 |
| 01:42 ET | 500 | 0.47 |
| 01:50 ET | 2500 | 0.47 |
| 01:51 ET | 2000 | 0.47 |
| 01:53 ET | 1000 | 0.47 |
| 02:02 ET | 500 | 0.47 |
| 02:11 ET | 2000 | 0.47 |
| 02:29 ET | 500 | 0.465 |
| 02:38 ET | 500 | 0.47 |
| 02:47 ET | 500 | 0.47 |
| 02:58 ET | 1500 | 0.475 |
| 03:02 ET | 500 | 0.47 |
| 03:03 ET | 2500 | 0.47 |
| 03:05 ET | 500 | 0.47 |
| 03:07 ET | 500 | 0.47 |
| 03:09 ET | 10000 | 0.47 |
| 03:18 ET | 3000 | 0.465 |
| 03:56 ET | 1000 | 0.4725 |
| 03:59 ET | 11000 | 0.48 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cybin Inc | 368.5M | -1.7x | --- |
Eupraxia Pharmaceuticals Inc | 140.7M | -2.5x | --- |
Cardiol Therapeutics Inc | 169.6M | -5.5x | --- |
Zentek Ltd | 155.8M | -12.6x | --- |
NervGen Pharma Corp | 143.7M | -5.5x | --- |
Alpha Cognition Inc | 101.7M | -3.5x | --- |
Company Information
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
Contact Information
- Headquarters
- 100 King Street West, Suite 5600TORONTO, ON, Canada M5X 1C9
- Phone
- 604-806-0626
- Fax
- 604-806-0626
Executives
- Executive Chairman of the Board, President, Co-founder
- Eric So
- Chief Executive Officer
- Douglas Drysdale
- Director, Co-founder, Chief Growth Officer
- Paul Glavine
- Chief Financial Officer
- Greg Cavers
- Chief Scientific Officer
- Alex Nivorozhkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $368.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 759.7M |
Cybin Inc does not pay a dividend. | |
Beta | -0.13 |
EPS | $-0.28 |
Book Value | $0.24 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
